ATE496134T1 - Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden - Google Patents
Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptidenInfo
- Publication number
- ATE496134T1 ATE496134T1 AT03808015T AT03808015T ATE496134T1 AT E496134 T1 ATE496134 T1 AT E496134T1 AT 03808015 T AT03808015 T AT 03808015T AT 03808015 T AT03808015 T AT 03808015T AT E496134 T1 ATE496134 T1 AT E496134T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- expression
- increased expression
- recombinant polypeptides
- materials
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 239000013598 vector Substances 0.000 title 1
- 238000013518 transcription Methods 0.000 abstract 3
- 230000035897 transcription Effects 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36853002P | 2002-03-29 | 2002-03-29 | |
PCT/US2003/010154 WO2004033693A1 (en) | 2002-03-29 | 2003-03-31 | Methods vectors plasmids and methods for increasing expression of recombinant polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496134T1 true ATE496134T1 (de) | 2011-02-15 |
Family
ID=32093683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03808015T ATE496134T1 (de) | 2002-03-29 | 2003-03-31 | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
Country Status (9)
Country | Link |
---|---|
US (4) | US7192737B2 (de) |
EP (2) | EP1492874B1 (de) |
JP (2) | JP4554370B2 (de) |
AT (1) | ATE496134T1 (de) |
AU (2) | AU2003300588B2 (de) |
CA (1) | CA2492008C (de) |
DE (1) | DE60335794D1 (de) |
DK (1) | DK1492874T3 (de) |
WO (1) | WO2004033693A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100311954A1 (en) * | 2002-03-01 | 2010-12-09 | Xencor, Inc. | Optimized Proteins that Target Ep-CAM |
DE60335794D1 (de) * | 2002-03-29 | 2011-03-03 | Xoma Technology Ltd | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
US20050009097A1 (en) * | 2003-03-31 | 2005-01-13 | Better Marc D. | Human engineered antibodies to Ep-CAM |
US20070224615A1 (en) * | 2003-07-09 | 2007-09-27 | Invitrogen Corporation | Methods for assaying protein-protein interactions |
EP2336768A1 (de) * | 2003-07-09 | 2011-06-22 | Life Technologies Corporation | Verfahren zum testen einer Protein-Protein-Wechselwirkung |
US20050202539A1 (en) * | 2004-03-11 | 2005-09-15 | Hydra Biosciences | System for screening eukaryotic membrane proteins |
US20060121604A1 (en) * | 2004-12-03 | 2006-06-08 | Xoma Technology Ltd. | Methods and materials for expression of a recombinant protein |
EP1833979A4 (de) * | 2004-12-14 | 2009-03-25 | Millennium Pharm Inc | Nukleinsäuremoleküle zur optimierten cab-2-expression und deren verwendung |
US20070072174A1 (en) * | 2005-09-28 | 2007-03-29 | Sayler Gary S | Bioreporter for detection of microbes |
EP1783228A1 (de) * | 2005-11-08 | 2007-05-09 | ETH Zürich | Rekombinante Expression von Multiproteinkomplexen mit Hilfe von Multigenen |
WO2007111661A2 (en) | 2006-03-20 | 2007-10-04 | Xoma Technology Ltd. | Human antibodies specific for gastrin materials and methods |
AR062435A1 (es) | 2006-08-18 | 2008-11-05 | Xoma Technology Ltd | Anticuerpo especifico prlr (receptor de prolactina) y sus usos |
MX2009006034A (es) | 2006-12-07 | 2009-10-12 | Novartis Ag | Anticuerpos antagonistas contra ephb3. |
RU2518340C2 (ru) * | 2007-03-30 | 2014-06-10 | Эббви Инк | Элементы рекомбинантного вектора экспрессии (reves) для усиления экспрессии рекомбинантных белков в клетках-хозяевах |
JP4997253B2 (ja) * | 2007-08-10 | 2012-08-08 | Toto株式会社 | 組換え哺乳動物細胞、組換え哺乳動物細胞の製造方法、および目的タンパク質の生産方法 |
CN101918579A (zh) | 2007-10-22 | 2010-12-15 | 先灵公司 | 完全人抗-vegf抗体和使用方法 |
US8318162B2 (en) * | 2009-07-16 | 2012-11-27 | Xoma Technology Ltd. | Antibodies to high molecular weight melanoma associated antigen |
PL2459721T3 (pl) * | 2009-07-29 | 2014-01-31 | Sigma Tau Ind Farmaceuti | Udoskonalony system ekspresji ludzkiej długiej pentraksyny i jego zastosowania |
WO2012011955A2 (en) * | 2010-07-21 | 2012-01-26 | Duke University | Compositions and methods for production and screening of monoclonal antibodies |
WO2012077128A1 (en) * | 2010-12-07 | 2012-06-14 | Intas Biopharmaceuticals Limited | A novel cell line development process to produce recombinant proteins using twin vector expression system |
EP3770263A1 (de) * | 2013-03-12 | 2021-01-27 | AGC Biologics, Inc. | Verbesserte rekombinante proteinexpression unter verwendung eines hybriden chef1-promotors |
US9388239B2 (en) | 2014-05-01 | 2016-07-12 | Consejo Nacional De Investigation Cientifica | Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B |
AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
JP2020501506A (ja) | 2016-09-07 | 2020-01-23 | イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. | 抗NKp46抗体およびその治療的使用 |
US10318741B2 (en) | 2016-11-21 | 2019-06-11 | Bank Of America Corporation | Data security and risk ranking tool |
IL253984A0 (en) | 2017-08-14 | 2017-09-28 | Yeda Res & Dev | Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1 |
CN111094566A (zh) * | 2017-08-23 | 2020-05-01 | 诺华股份有限公司 | 多拷贝基因蛋白表达系统 |
CA3069238A1 (en) * | 2017-11-02 | 2019-05-09 | Systimmune, Inc. | Bispecific antibodies and methods of making and using thereof |
IL276627A (en) | 2020-08-10 | 2022-03-01 | Yeda Res & Dev | Compositions for diagnosis and treatment of coronavirus infections |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4612282A (en) | 1981-12-15 | 1986-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Monoclonal antibodies reactive with human breast cancer |
IN163393B (de) * | 1983-10-06 | 1988-09-17 | Pfizer | |
US4880741A (en) | 1983-10-06 | 1989-11-14 | Pfizer Inc. | Process for transformation of Yarrowia lipolytica |
US5198541A (en) | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US5576184A (en) | 1988-09-06 | 1996-11-19 | Xoma Corporation | Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
GB9115364D0 (en) | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
CA2103887C (en) | 1991-12-13 | 2005-08-30 | Gary M. Studnicka | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
ES2132239T3 (es) | 1992-05-19 | 1999-08-16 | Xoma Corp | Metodos mejorados para la preparacion de proteinas de union a endotoxinas. |
US5643570A (en) | 1992-05-19 | 1997-07-01 | Xoma Corporation | BPI-immunoglobulin fusion proteins |
US5420019A (en) | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
US5348942A (en) | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
ATE169304T1 (de) | 1993-03-12 | 1998-08-15 | Xoma Corp | Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung |
US5733872A (en) | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5858974A (en) | 1995-07-20 | 1999-01-12 | Xoma Corporation | Anti-fungal peptides |
US5652332A (en) | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
JPH08509703A (ja) | 1993-03-12 | 1996-10-15 | ゾーマ コーポレイション | 殺菌/透過性増加タンパク質産物の治療用途 |
US5447913A (en) | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
ATE256147T1 (de) | 1994-09-15 | 2003-12-15 | Xoma Technology Ltd | Peptide gegen pilzen |
US5866402A (en) | 1995-05-05 | 1999-02-02 | Chiron Corporation | Chimeric MCP and DAF proteins with cell surface localizing domain |
US5851802A (en) | 1996-03-22 | 1998-12-22 | Xoma Corporation | Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
US5998174A (en) * | 1997-05-12 | 1999-12-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Multigene vectors |
US6013631A (en) | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
EP2278022A3 (de) | 1999-11-01 | 2011-05-18 | Novartis Vaccines and Diagnostics, Inc. | Expressionsvektoren, Transfektionssysteme und Verfahren zu deren Verwendung |
US6908751B2 (en) * | 2000-04-26 | 2005-06-21 | Zymogenetics, Inc. | Methods for enhancing the expression of a protein of interest by recombinant host cells |
DE60335794D1 (de) * | 2002-03-29 | 2011-03-03 | Xoma Technology Ltd | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
US9320293B2 (en) | 2008-06-06 | 2016-04-26 | Gold Medal Products Company | Popcorn kettle |
US9402401B1 (en) | 2008-11-03 | 2016-08-02 | William P. Benzel | Extruded three loop pretzel having a twist-knot appearance at its middle portion, apparatus and die for making said pretzel, and method of forming said pretzel |
US9304754B2 (en) | 2009-10-28 | 2016-04-05 | Advanced Businesslink Corporation | Modernization of legacy applications using dynamic icons |
KR101858484B1 (ko) | 2010-12-28 | 2018-06-27 | 히타치 긴조쿠 가부시키가이샤 | 페라이트 소결 자석 및 그 제조 방법 |
WO2013172339A1 (ja) | 2012-05-15 | 2013-11-21 | 大鵬薬品工業株式会社 | 腹圧性尿失禁予防剤及び/又は治療剤 |
US9410427B2 (en) | 2012-06-05 | 2016-08-09 | United Technologies Corporation | Compressor power and torque transmitting hub |
WO2014066407A1 (en) | 2012-10-22 | 2014-05-01 | ZS Pharma, Inc. | Microporous zirconium silicate for treating hyperkalemia |
JP6453542B2 (ja) | 2013-02-14 | 2019-01-16 | ソウル セミコンダクター カンパニー リミテッド | 半導体装置及びこれの製造方法 |
KR20150087669A (ko) | 2014-01-22 | 2015-07-30 | 삼성전기주식회사 | 컨커런트 다중밴드 고주파 증폭회로 |
US9503125B2 (en) | 2014-05-08 | 2016-11-22 | Sandisk Technologies Llc | Modified trellis-based min-max decoder for non-binary low-density parity-check error-correcting codes |
US9402465B1 (en) | 2014-06-11 | 2016-08-02 | Paul Edward LaForge | Shaving brush with vented holder |
US9218176B1 (en) | 2014-06-13 | 2015-12-22 | International Business Machines Corporation | Software deployment in a distributed virtual machine environment |
-
2003
- 2003-03-31 DE DE60335794T patent/DE60335794D1/de not_active Expired - Lifetime
- 2003-03-31 EP EP03808015A patent/EP1492874B1/de not_active Expired - Lifetime
- 2003-03-31 DK DK03808015.6T patent/DK1492874T3/da active
- 2003-03-31 AT AT03808015T patent/ATE496134T1/de not_active IP Right Cessation
- 2003-03-31 CA CA2492008A patent/CA2492008C/en not_active Expired - Lifetime
- 2003-03-31 AU AU2003300588A patent/AU2003300588B2/en not_active Expired
- 2003-03-31 US US10/404,724 patent/US7192737B2/en active Active
- 2003-03-31 WO PCT/US2003/010154 patent/WO2004033693A1/en active Application Filing
- 2003-03-31 EP EP10011422A patent/EP2311962B1/de not_active Expired - Lifetime
- 2003-03-31 JP JP2004543182A patent/JP4554370B2/ja not_active Expired - Lifetime
-
2006
- 2006-03-03 JP JP2006058763A patent/JP2006141415A/ja not_active Withdrawn
-
2007
- 2007-02-09 US US11/673,539 patent/US7993915B2/en active Active
- 2007-08-07 US US11/835,131 patent/US20080145895A1/en not_active Abandoned
-
2009
- 2009-03-03 AU AU2009200829A patent/AU2009200829A1/en not_active Abandoned
-
2011
- 2011-08-08 US US13/205,448 patent/US8497096B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2003300588A1 (en) | 2004-05-04 |
WO2004033693A1 (en) | 2004-04-22 |
DE60335794D1 (de) | 2011-03-03 |
US8497096B2 (en) | 2013-07-30 |
US20080145895A1 (en) | 2008-06-19 |
JP2006141415A (ja) | 2006-06-08 |
JP4554370B2 (ja) | 2010-09-29 |
EP1492874B1 (de) | 2011-01-19 |
AU2003300588B2 (en) | 2008-12-04 |
CA2492008C (en) | 2012-06-26 |
US7192737B2 (en) | 2007-03-20 |
DK1492874T3 (da) | 2011-03-14 |
CA2492008A1 (en) | 2004-04-22 |
US20030203447A1 (en) | 2003-10-30 |
JP2005528925A (ja) | 2005-09-29 |
AU2009200829A1 (en) | 2009-03-19 |
US20070281334A1 (en) | 2007-12-06 |
EP2311962A1 (de) | 2011-04-20 |
EP2311962B1 (de) | 2013-03-13 |
US20120178126A1 (en) | 2012-07-12 |
EP1492874A1 (de) | 2005-01-05 |
US7993915B2 (en) | 2011-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE496134T1 (de) | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden | |
ATE454393T1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
DE60227064D1 (de) | Von rna polymerasen abstammende polypeptide und ihre verwendungen | |
DE69838334D1 (de) | Kdr, ein menschlicher tyrosin kinase rezeptor | |
ATE301716T1 (de) | Vmp-ähnliche sequenzen von pathogener borrelia | |
BRPI0516504A (pt) | polipeptìdeo tendo atividade de fitase e seqüência de nucleotìdeo codificando o mesmo | |
ATE504645T1 (de) | Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon | |
EP1482047A4 (de) | PROTEIN ODER POLYPEPTID MIT LACHRYMATORSYNTHASEAKTIVITÄT, DAS PROTEIN ODER POLYPEPTID CODIERENDE DNA, VERFAHREN ZUR HERSTELLUNG VON PROTEIN ODER POLYPEPTID MIT LACHRYMATORSYNTHASEAKTIVITÄT UNTER VERWENDUNG DER DNA SOWIE DIE TRANSLATION DER DAS PROTEIN ODER PEPTID BETREFFENDEN mRNA HEMMENDES NUKLEINSÄUREMOLEKÜL | |
BR9902019A (pt) | Moléculas de polinucleotìdios que codificam proteìnas de neospora. | |
ATE532861T1 (de) | Expressionsvektor | |
HUP0500349A2 (hu) | Eljárás polipeptidek előállítására | |
DE602004021922D1 (de) | Induktion der blütenbildung | |
DK1716237T3 (da) | Orotat-transportørkodende markørgener | |
ATE546534T1 (de) | Expression system für rekombinante proteine | |
ATE556140T1 (de) | Aav vektoren für die gentherapie von rheumatischer arthritis | |
WO2003074675A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
ATE423200T1 (de) | Neues plexin-polypeptid, dieses codierende dna und verwendung davon | |
HUP0200832A2 (hu) | Babesia canis oltóanyag | |
WO2002077190A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2003070882A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof | |
CO5400145A1 (es) | Proteina asociada con enfermedad | |
WO2002079494A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002074976A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
ECSP993160A (es) | Acidos nucleicos y polipeptidos homologos il-17, vectores,celulas huesped, metodos y usos de los mismos | |
WO2002068648A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |